3DUnit | DRUG DISCOVERY & DEVELOPMENT RESEARCH UNIT
Molecular Pharmacology and Cancer Therapeutics

OVERVIEW


The main research focus at 3DUnit is the identification of pharmacological modulators of human cancer-related proteins through an approach that combines yeast, human cell lines and animal models.

The research activities of the group are mainly focused on:
• Development of yeast models for functional and molecular studies of human disease-related proteins: yeast targeted screening assays
• Molecular and pharmacological studies in human tumor cell lines
• In vitro drug-protein binding assays
• Pharmacological studies in human tumor xenografts mice models


NEWS
http://nortexcel2020.eu/about-nortexcel/ne2020/med-ideas-cancer
3DUnit received a MED.IDEAS award, promoted by NORTEXCEL
ACTONp53 was one of the selected projects for the CANCER area, proposing p53-activating agents as new anticancer drug candidates. [Link]

"Ajudar a vencer o cancro é o sonho de qualquer investigador nesta área" 
An interview with Prof. Lucília Saraiva was featured on "À conversa com os inventores" on the newsletter of U.Porto Inovação. [Link]